iNfinitesimal is a nanotechnology company developing tools for targeted and controlled cellular delivery of biomolecules, drugs, nanoparticles, or other chemicals in liquid solution. The firm is focused on development of emergent nano- and bio-technologies from the laboratory into commercial tools that provide capabilities to researchers. Through funding by NIH, the firm is developing automated single-cell electroporation using the nanofountain probe electroporation system.
